Your request to link to MMDB for ATIII/alphaIIa
MMDB Description | |
---|---|
55315 | Human Cyclin Dependent Kinase 2 Complexed With the Inhibitor Staurosporine |
86690 | Human Cyclin-dependent Kinase 2 |
86691 | Human Cyclin-dependent Kinase 2 Phosphorylated on THR 160 |
11979 | Crystal Structure of the Human Cdk2 Kinase Complex With Cell Cycle-regulatory Protein Ckshs1 |
12188 | Human Cyclin Dependent Kinase 2 Complexed With the Inhibitor Purvalanol B |
14472 | The Structure of Cyclin-dependent Kinase 2 (Cdk2) in Complex With 4-[3-hydroxyanilino]-6,7-dimethoxyquinazoline |
13361 | Human Cyclin-dependent Kinase 2 Complexed With the Inhibitor Hymenialdisine |
91067 | Human Cyclin Dependent Kinase 2 Complexed With the Inhibitor Nu2058 |
91068 | Human Cyclin Dependent Kinase 2 Complexed With the Inhibitor Nu6027 |
48841 | THR 160 Phosphorylated Cdk2-human Cyclin A3 Complex With the Inhibitor Indirubin-5-sulphonate Bound |
14968 | Crystal Structure of Murine Gamma Herpesvirus Cyclin Complexed to Human Cyclin Dependent Kinase 2 |
5224 | Cyclin A-cyclin-dependent Kinase 2 Complex |
16075 | Crystal Structure of Kinase Associated Phosphatase (Kap) in Complex With Phospho-cdk2 |
15423 | The Structure of Cyclin-dependent Kinase 2 (Cdk2) in Complex With an Oxindole Inhibitor |
15424 | The Structure of Cdk2cyclin a in Complex With an Oxindole Inhibitor |
17593 | Crystal Structure of Human Cyclin Dependent Kinase 2 (Cdk2) in Complex With the Inhibitor H717 |
18391 | Human Cyclin Dependent Kinase 2 Complexed With the Cdk4 Inhibitor |
18392 | Human Cyclin Dependent Kinase 2 Complexed With the Cdk4 Inhibitor |
18393 | Human Cyclin Dependent Kinase 2 Complexed With the Cdk4 Inhibitor |
19416 | Pcdk2cyclin a in Complex With Mgadp, Nitrate and Peptide Substrate |
72206 | Human Cyclin Dependent Kinase 2 Complexed With the Inhibitor 2-amino-6-(3'-methyl-2'-oxo)butoxypurine |
91106 | Cdk2 in Complex With a Disubstituted 4, 6-bis Anilino Pyrimidine Cdk4 Inhibitor |
23817 | Cdk2 in Complex With a Disubstituted 2, 4-bis Anilino Pyrimidine Cdk4 Inhibitor |
91107 | Cdk2 in Complex With a Disubstituted 4, 6-bis Anilino Pyrimidine Cdk4 Inhibitor |
91108 | Cdk2 in Complex With a Disubstituted 2, 4-bis Anilino Pyrimidine Cdk4 Inhibitor |
23241 | Human Cyclin Dependent Protein Kinase 2 in Complex With the Inhibitor 2-amino-6-[(r)-pyrrolidino-5'-yl]methoxypurine |
23242 | Human Cyclin Dependent Protein Kinase 2 in Complex With the Inhibitor 2-amino-6-[cyclohex-3-enyl]methoxypurine |
20562 | Structure of Human Thr160-phospho Cdk2cyclin a Complexed With the Inhibitor Nu2058 |
20563 | Structure of Human Thr160-phospho Cdk2cyclin a Complexed With the Inhibitor Nu6094 |
20564 | Structure of Human Thr160-phospho Cdk2cyclin a Complexed With the Inhibitor Nu6086 |
20565 | Structure of Human Thr160-phospho Cdk2cyclin a Complexed With the Inhibitor Nu6102 |
21606 | Cdk2cyclin a in Complex With a 9 Residue Recruitment Peptide From E2F |
21607 | Cdk2cyclin a in Complex With an 11-residue Recruitment Peptide From Retinoblastoma-associated Protein |
21608 | Cdk2cyclin a in Complex With an 11-residue Recruitment Peptide From P53 |
21609 | Cdk2cyclin a in Complex With an 11-residue Recruitment Peptide From P27 |
21610 | Cdk2cyclin a in Complex With an 11-residue Recruitment Peptide From P107 |
56308 | Human Cyclin-dependent Kinase 2 |
56309 | Human Cyclin-dependent Kinase 2 |
5324 | Phosphorylated Cyclin-dependent Kinase-2 Bound to Cyclin a |
49840 | P27(kip1)cyclin Acdk2 Complex |
17097 | The Structure of Cyclin-dependent Kinase 2 (Cdk2) in Complex With 4-[(6-amino-4-pyrimidinyl) Amino]benzenesulfonamide |
18308 | Crystal Structure of Human Cdk2 (Unphosphorylated) in Complex With Pkf049-365 |
19534 | Cdk2 Complexed With N-methyl-4-{[(2-oxo-1,2-dihydro-3h- Indol-3-ylidene)methyl]amino}benzenesulfonamide |
19535 | Cyclin-dependent Kinase 2 (Cdk2) Complexed With N-methyl-{4- [2-(7-oxo-6,7-dihydro-8h-[1,3]thiazolo[5,4-e]indol-8- Ylidene)hydrazino]phenyl}methanesulfonamide |
19536 | Cyclin-dependent Kinase 2 (Cdk2) Complexed With 3-{[(2,2- Dioxido-1,3-dihydro-2-benzothien-5-yl)amino]methylene}-5- (1,3-oxazol-5-yl)-1,3-dihydro-2h-indol-2-one |
19537 | Cyclin-dependent Kinase 2 (Cdk2) Complexed With 4-{[(2-oxo- 1,2-dihydro-3h-indol-3-ylidene)methyl]amino}-n-(1,3- Thiazol-2-yl)benzenesulfonamide |
19538 | Cyclin-dependent Kinase 2 (Cdk2) Complexed With 3-{[4- ({[amino(imino)methyl]aminosulfonyl)anilino]methylene}-2- Oxo-2,3-dihydro-1h-indole |
23920 | Structure of Human Thr160-phospho Cdk2cyclin a Complexed With a 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- Aminopyrimidine Inhibitor |
28467 | Structure of Human Thr160-phospho Cdk2cyclin a Complexed With a 6-cyclohexylmethyloxy-2-anilino-purine Inhibitor |
50636 | Imidazopyridines: a Potent and Selective Class of Cyclin- Dependent Kinase Inhibitors Identified Through Structure- Based Hybridisation |
50637 | Imidazopyridines: a Potent and Selective Class of Cyclin- Dependent Kinase Inhibitors Identified Through Structure- Based Hybridisation |
50639 | Imidazopyridines: a Potent and Selective Class of Cyclin- Dependent Kinase Inhibitors Identified Through Structure- Based Hybridisation |
28468 | Structure of Human Thr160-phospho Cdk2cyclin a Complexed With a 6-cyclohexylmethyloxy-2-anilino-purine Inhibitor |
28469 | Structure of Human Thr160-phospho Cdk2cyclin a Complexed With a 6-cyclohexylmethyloxy-2-anilino-purine Inhibitor |
74114 | Cyclin a Binding Groove Inhibitor H-arg-arg-leu-ile-phe-nh2 |
74115 | Cyclin a Binding Groove Inhibitor Ac-arg-arg-leu-asn- (M-cl-phe)-nh2 |
73405 | Cyclin a Binding Groove Inhibitor H-cit-cit-leu-ile-(p-f-phe)-nh2 |
74116 | Cyclin a Binding Groove Inhibitor H-arg-arg-leu-asn-(p-f-phe)-nh2 |
24473 | The Structure of Cyclin Dependent Kinase 2 (Ckd2) With a Trisubstituted Naphthostyril Inhibitor |
23597 | The Strucure of Phospho-cdk2cyclin a in Complex With the Inhibitor 4,5,6,7-tetrabromobenzotriazole (Tbs) |
25687 | Crystal Structure of Human Cyclin-dependent Kinase 2 Complexed With a Nucleoside Inhibitor |
23656 | The Crystal Structure of Ucn-01 in Complex With Phospho- Cdk2cyclin a |
25698 | APO Structure of Human Cyclin-dependent Kinase 2 |
25700 | Human Cyclin Dependent Kinase 2 Complexed With the Inhibitor 4-(2,5-dichloro-thiophen-3-yl)-pyrimidin-2- Ylamine |
25701 | Human Cyclin Dependent Kinase 2 Complexed With the Inhibitor 4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-ylamine |
25702 | Human Cyclin Dependent Kinase 2 Complexed With the Inhibitor N-[4-(2,4-dimethyl-thiazol-5-yl)pyrimidin-2-yl]- N'-hydroxyiminoformamide |
25703 | Human Cyclin Dependent Kinase 2 Complexed With the Inhibitor [4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-yl]- (4-trifluoromethyl-phenyl)-amine |
27269 | Human Cyclin Dependent Kinase 2 Complexed With the Inhibitor 3-[4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2- Ylamino]-phenol |
27270 | Human Cyclin Dependent Kinase 2 Complexed With the Inhibitor 4-[4-(4-methyl-2-methylamino-thiazol-5-yl)- Pyrimidin-2-ylamino]-phenol |
27271 | Human Cyclin Dependent Kinase 2 Complexed With the Inhibitor [4-(2-amino-4-methyl-thiazol-5-yl)-pyrimidin-2- Yl]-(3-nitro-phenyl)-amine |
27272 | Human Cyclin Dependent Kinase 2 Complexed With the Inhibitor N-[4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-yl]- N',n'-dimethyl-benzene-1,4-diamine |
28501 | Crystal Structure of Cdk2 With Inhibitor |
11811 | Phosphorylated Cdk2-cyclyin A-substrate Peptide Complex |
26171 | Cdk2 Complex With a 4-alkynyl Oxindole Inhibitor |
74367 | Cyclin a Binding Groove Inhibitor Ace-arg-lys-leu- Phe-gly |
51705 | Cdk2 in Complex With an Imidazo[1,2-b]pyridazine |
51756 | Cdk2 in Complex With a Disubstituted 4, 6-bis Anilino Pyrimidine Cdk4 Inhibitor |
28447 | Structure of Cdk2cyclin a With Pnu-292137 |
28448 | Structure of Cdk2 Complexed With Pnu-181227 |
31343 | Crystals Structure of Human Cdk2 in Complex With the Inhibitor Olomoucine |
51877 | Co-crystal Structure of 6-cyclohexylmethoxy-8-isopropyl-9h- Purin-2-ylamine and Monomeric Cdk2 |
31900 | The Structural Basis of Cdk2 Activation by Cyclin E |
31391 | Screening for Fragment Binding by X-ray Crystallography |
32043 | Crystal Structure of Human Cdk2 Complexed With a Pyrazolo[1, 5-a]pyrimidine Inhibitor |
32044 | Crystal Structure of Human Cdk2 Complexed With a Pyrazolo[1, 5-a]pyrimidine Inhibitor |
36955 | Crystal Structure of Cdk2 With an Aminoimidazo Pyridine Inhibitor |
37020 | Human Cdk2 in Complex With Olomoucine II, a Novel 2,6,9- Trisubstituted Purine Cyclin-dependent Kinase Inhibitor |
41297 | Human Cyclin-dependent Kinase 2 in Complex With Roscovitine |
35692 | Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Dph- 042562 |
35693 | Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Din- 234325 |
35694 | Human Cyclin Dependent Kinase 2 (Ckd2)complexed With Din- 232305 |
35695 | Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Indenopyraxole Din-101312 |
32662 | Human Cyclin Dependent Protein Kinase 2 in Complex With the Inhibitor 5-bromo-indirubine |
32663 | Human Cyclin Dependent Protein Kinase 2 in Complex With the Inhibitor 4-hydroxypiperindinesulfonyl-indirubine |
38056 | Structure of Cdk2-cyclin a With Pha-404611 |
36731 | Structure of Cdk2-cyclin a With Pha-630529 |
36215 | Structure of Cdk2 Complexed With Pnu-198873 |
36216 | Structure of Cdk2 Complexed With Pnu-230032 |
36260 | Structure of Cdk2-cyclin a With Pha-533514 |
38076 | Differential Binding of Inhibitors to Active and Inactive Cdk2 Provides Insights for Drug Design |
38077 | Differential Binding of Inhibitors to Active and Inactive Cdk2 Provides Insights for Drug Design |
86903 | Differential Binding of Inhibitors to Active and Inactive Cdk2 Provides Insights for Drug Design |
38081 | Differential Binding of Inhibitors to Active and Inactive Cdk2 Provides Insights for Drug Design |
38082 | Differential Binding of Inhibitors to Active and Inactive Cdk2 Provides Insights for Drug Design |
86905 | Crystal Structure of the Human Cdk2 Complexed With the Triazolopyrimidine Inhibitor |
36760 | Crystal Structure of the Human Cdk2 Complexed With the Triazolopyrimidine Inhibitor |
36761 | Crystal Structure of the Human Cdk2 Complexed With the Triazolopyrimidine Inhibitor |
36762 | Crystal Structure of the Human Cdk2 Complexed With the Triazolopyrimidine Inhibitor |
36763 | Crystal Structure of the Human Cdk2 Complexed With the Triazolopyrimidine Inhibitor |
86907 | Crystal Structure of the Human Cdk2 Complexed With the Triazolopyrimidine Inhibitor |
86908 | Crystal Structure of the Human Cdk2 Complexed With the Triazolopyrimidine Inhibitor |
36766 | Crystal Structure of the Human Cdk2 Complexed With the Triazolopyrimidine Inhibitor |
39101 | The Crystal Structure of Cdk2 Cyclin a in Complex With a Substrate Peptide Derived From CDC Modified With a Gamma- Linked ATP Analogue |
39102 | Crystal Structure of Phospho-cdk2 Cyclin a in Complex With a Peptide Containing Both the Substrate and Recruitment Sites of Cdc6 |
38626 | Mechanism of CDK Inhibition by Active Site Phosphorylation: Cdk2 Y15p T160p in Complex With Cyclin a Structure |
42581 | 4-arylazo-3,5-diamino-1h-pyrazole CDK Inhibitors: SAR Study, Crystal Structure in Complex With Cdk2, Selectivity, and Cellular Effects |
46879 | Human Cyclin Dependent Kinase 2 Complexed With the Cdk4 Inhibitor |
43718 | Structure of Cdk2 With a 3-hydroxychromones |
36838 | Human Cdk2 in Complex With Isopentenyladenine |
42189 | Cyclin Dependent Kinase 2 (Cdk2) With Diaminopyrimidine Inhibitor |
39347 | Structure of THR 160 Phosphorylated Cdk2cyclin a in Complex With the Inhibitor Nu6271 |
42325 | Cdk2cyclin a Complexed With a Thiophene Carboxamide Inhibitor |
41817 | Structure of Human Thr160-phospho Cdk2-cyclin a Complexed With a Bisanilinopyrimidine Inhibitor |
41818 | Structure of Human Thr160-phospho Cdk2-cyclin a F82h-l83v- H84d Mutant With an O6-cyclohexylmethylguanine Inhibitor |
41819 | Structure of Human Thr160-phospho Cdk2-cyclin a Complexed With a Bisanilinopyrimidine Inhibitor |
60474 | Crystal Structure of Cdk2 in Complex With Macrocyclic Aminopyrimidine |
46324 | Crystal Structure of Phospho-cdk2 in Complex With Cyclin B |
61984 | Crystal Structure of Cyclin-dependent Kinase 2 With Inhibitor |
61985 | Crystal Structure of Cyclin-dependent Kinase 2 With Inhibitor |
61986 | Crystal Structure of Cyclin-dependent Kinase 2 With Inhibitor |
61987 | Crystal Structure of Cyclin-dependent Kinase 2 With Inhibitor |
61988 | Crystal Structure of Cyclin-dependent Kinase 2 With Inhibitor |
61989 | Crystal Structure of Cyclin-dependent Kinase 2 With Inhibitor |
61990 | Crystal Structure of Cyclin-dependent Kinase 2 With Inhibitor |
61991 | Crystal Structure of Cyclin-dependent Kinase 2 With Inhibitor |
61992 | Crystal Structure of Cyclin-dependent Kinase 2 With Inhibitor |
61993 | Crystal Structure of Cyclin-dependent Kinase 2 With Inhibitor |
61994 | Crystal Structure of Cyclin-dependent Kinase 2 With Inhibitor |
61995 | Crystal Structure of Cyclin-dependent Kinase 2 With Inhibitor |
61996 | Crystal Structure of Cyclin-dependent Kinase 2 With Inhibitor |
66553 | Crystal Structure of a 3-aminoindazole Compound With Cdk2 |
45391 | Replace: a Strategy for Iterative Design of Cyclin Binding Groove Inhibitors |
47311 | Crystal Structure of Human Cdk2 Complexed With a Thiazolidinone Inhibitor |
47312 | Crystal Structure of Human Cdk2 Complexed With a Thiazolidinone Inhibitor |
47313 | Crystal Structure of Human Cdk2 Complexed With a Thiazolidinone Inhibitor |
47315 | Crystal Structure of Human Cdk2 Complexed With a Thiazolidinone Inhibitor |
47316 | Crystal Structure of Human Cdk2 Complexed With a Thiazolidinone Inhibitor |
47317 | Crystal Structure of Human Cdk2 Complexed With a Thiazolidinone Inhibitor |
47319 | Crystal Structure of Human Cdk2 Complexed With a Thiazolidinone Inhibitor |
62126 | Replace: a Strategy for Iterative Design of Cyclin Binding Groove Inhibitors |
65828 | Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (At7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design |
65829 | Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (At7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design |
65830 | Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (At7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design |
65831 | Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (At7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design |
65832 | Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (At7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design |
65833 | Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (At7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design |
65834 | Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (At7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design |
65835 | Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (At7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design |
65836 | Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (At7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design |
65837 | Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (At7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design |
65838 | Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (At7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design |
65839 | Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (At7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design |
65840 | Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (At7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design |
65841 | Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (At7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design |
65845 | Cdk2 in Complex With an Imidazole Piperazine |
67301 | Structure of Cdk2 in Complex With an Imidazolyl Pyrimidine, Compound 5B |
66860 | Structure of Cdk2 in Complex With an Imidazolyl Pyrimidine, Compound 5C |
67710 | Cdk2 in Complex With the Imidazole Pyrimidine Amide, Compound (S)-8b |
69247 | Fragment-based Discovery of the Pyrazol-4-yl Urea (At9283), a Multi-targeted Kinase Inhibitor With Potent Aurora Kinase Activity |
82117 | Truncation and Optimisation of Peptide Inhibitors of Cdk2, Cyclin a Through Structure Guided Design |
73105 | Truncation and Optimisation of Peptide Inhibitors of Cdk2, Cyclin a Through Structure Guided Design |
73109 | Truncation and Optimisation of Peptide Inhibitors of Cdk2, Cyclin a Through Structure Guided Design |
75550 | Structure of Cdk2-cyclin a With Pha-848125 |
75551 | Structure of Cdk2-cyclin a Complexed With 8-anilino-1- Methyl-4,5-dihydro-1h-pyrazolo[4,3-h] Quinazoline-3- Carboxylic Acid |
84494 | Structural and Thermodynamic Consequences of Cyclization of Peptide Ligands for the Recruitment Site of Cyclin a |
84495 | Structural and Thermodynamic Consequences of Cyclization of Peptide Ligands for the Recruitment Site of Cyclin a |
80223 | Optimisation of 6,6-dimethyl Pyrrolo 3,4-c Pyrazoles: Identification of Pha-793887, a Potent CDK Inhibitor Suitable for Intravenous Dosing |
80229 | Structure of Cdk2-cyclin a With a Pyrazolo(4,3-h) Quinazoline-3-carboxamide Inhibitor |
80073 | Truncation and Optimisation of Peptide Inhibitors of Cdk2, Cyclin a Through Structure Guided Design |
86033 | Discovery and Characterisation of 2-anilino-4-(thiazol-5-yl) Pyrimidine Transcriptional CDK Inhibitors as Anticancer Agents |
86035 | Discovery and Characterisation of 2-anilino-4-(thiazol-5-yl) Pyrimidine Transcriptional CDK Inhibitors as Anticancer Agents |
62420 | Structure of Phosphorylated Thr160 Cdk2cyclin a in Complex With the Inhibitor Meriolin 3 |
62421 | Structure of Phosphorylated Thr160 Cdk2cyclin a in Complex With the Inhibitor Meriolin 5 |
62422 | Structure of Phosphorylated Thr160 Cdk2cyclin a in Complex With the Inhibitor Variolin B |
65636 | Structure of Phosphorylated Thr160 Cdk2cyclin a in Complex With the Inhibitor CR8 |
65637 | Structure of Phosphorylated Thr160 Cdk2cyclin a in Complex With the Inhibitor Roscovitine |
67039 | Structure of THR 160 Phosphorylated Cdk2cyclin a in Complex With the Inhibitor N-&-n1 |
67507 | Cdk2cyclina Complexed With a Pyrazolopyridazine Inhibitor |
67508 | Cdk2cyclina Complexed With a Pyrazolopyridazine Inhibitor |
67795 | Cdk2cyclina Complexed With a Imidazo Triazin-2-amine |
69433 | Cdk-2 With Indazole Inhibitor 17 Bound at ITS Active Site |
69434 | Cdk-2 With Indazole Inhibitor 9 Bound at ITS Active Site |
69436 | Cdk-2-cyclin Complex With Indazole Inhibitor 9 Bound at ITS Active Site |
70716 | Crystal Structure of a Benzthiophene Inhibitor Bound to Human Cyclin-dependent Kinase-2 (Cdk-2) |
76611 | Novel Cdk-5 Inhibitors - Crystal Structure of Inhibitor EFP With Cdk-2 |
76612 | Novel Cdk-5 Inhibitors - Crystal Structure of Inhibitor EFQ With Cdk-2 |
86234 | The Structure of Cyclin Dependent Kinase 2 (Ckd2) With a Pyrazolobenzodiazepine Inhibitor |
80523 | Crystal Structure of Cdk2 With Sar57, an Aminoindazole Type Inhibitor |
80524 | Crystal Structure of Cdk2 With Sar60, an Aminoindazole Type Inhibitor |
80525 | Crystal Structure of Cdk2 With Sar37, an Aminoindazole Type Inhibitor |
85224 | Cdk2cyclina in Complex With DRB |
87178 | Crystal Structure of Cdk2 in Complex With Inhibitor Bs-194 |
89696 | Structure of Cdk2 in Complex With a Pyrazolo[4,3-d]pyrimidine Bioisostere of Roscovitine |
88696 | Cdk2 in Complex With Two Molecules of 8-anilino-1-naphthalene Sulfonate |
88698 | Cdk2 in Complex With 3 Molecules of 8-anilino-1-naphthalene Sulfonate |
88699 | APO Cdk2 Crystallized From Jeffamine |
88700 | Cdk2 in Complex With Inhibitor Jws648 |
88701 | Cdk2 Ternary Complex With Jws648 and ANS |
88702 | Cdk2 in Complex With Inhibitor Su9516 |
88703 | Cdk2 Ternary Complex With Su9516 and ANS |
90830 | Structure of a Pcdk2cyclina Transition-state Mimic |
90831 | Structure of a Pcdk2cyclina Transition-state Mimic |